A Boxed Warning explaining the risk of medication errors involving inadvertent neuraxial administration will be added to the labeling. The Food and Drug Administration (FDA) has issued an updated ...
Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. jointly announced, that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback